Mirum Pharmaceuticals, Inc. MIRM NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score

52/100

2/7 Pass

SharesGrow Intrinsic Value

Mirum Pharmaceuticals, Inc. (MIRM) 的分析师一致评级为 Buy, 基于 18 位分析师覆盖该股票. 其中, 18 建议买入, 0 建议持有, and 0 建议卖出.

分析师对 MIRM is $116.70, 代表 +20.4% 上涨空间较当前价格 $96.9. 目标价格区间从最低 $95.00 到最高 $140.00.

分析师共识 — MIRM

Buy

强力买入

买入

持有

卖出

强力卖出

18 位分析师

价格目标

共识$116.70

最高$140.00

最低$95.00

中位数$122.00

上月均价-

上季均价$116.25

去年均价$105.19

历史总数35

其他人也在看

BPMC

Blueprint Medicines Corporation

$129.46

+0.14%

CERE

Cerevel Therapeutics Holdings, Inc.

$44.96

+0.74%

APLS

Apellis Pharmaceuticals, Inc.

$40.85

+0.02%

TERN

Terns Pharmaceuticals, Inc.

$52.68

+0.13%

ARQT

Arcutis Biotherapeutics, Inc.

$25.09

+4.02%

DAWN

Day One Biopharmaceuticals, Inc.

$21.46

-0.14%

IMCR

Immunocore Holdings plc

$31.69

+0.70%

AMLX

Amylyx Pharmaceuticals, Inc.

$16.92

+2.73%

Mirum Pharmaceuticals, Inc. MIRM NASDAQ

分析师共识 — MIRM

其他人也在看

获取低估股票提醒